Abstract
We report the case of a 35-year-old male with a history of chronic, escalating nitrous oxide abuse who presented to the ER with a history of recent onset generalized weakness, altered sensorium, abnormal posturing of the hands, urinary complaints, and decreased balance. Physical examination was notable for pathologically brisk reflexes in all extremities, generalized flexion contracture of the fingers, decreased sensation in a stocking and glove distribution, and a weakly positive Babinski sign. The patient was noted to be a poor historian with decreased attention and concentration though otherwise generally alert and oriented. No discrete sensory level in the chest or trunk was detected, and the overall clinical appearance was felt to be most compatible with a mixed myeloneuropathic pattern of central and peripheral involvement. Laboratory findings were normal and noncontributory. Cervical spine MRI subsequently performed to rule out cord compression, intrinsic spinal cord mass, or demyelinating disease was notable for a long segment of increased T2 signal extending from C2–C3 to C6–C7 localizing to the dorsal columns of the cord in a typical “inverted V” fashion. No associated cord expansion was seen nor was there evidence of extrinsic compression; faint associated contrast enhancement was observed on post-gadolinium images. Further evaluation with nerve conduction velocity and electromyographic testing was deferred. Based on the exam findings, clinical history, and presentation, a diagnosis of nitrous oxide-related myeloneuropathy was made, and treatment with high-dose vitamin B12 supplementation was instituted. Recovery has been slow to date.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10140-013-1152-6/MediaObjects/10140_2013_1152_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10140-013-1152-6/MediaObjects/10140_2013_1152_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10140-013-1152-6/MediaObjects/10140_2013_1152_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10140-013-1152-6/MediaObjects/10140_2013_1152_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10140-013-1152-6/MediaObjects/10140_2013_1152_Fig5_HTML.jpg)
Similar content being viewed by others
References
Hsu C, Chen Y, Lung V, His S, Lo H, Shyu H (2012) Myelopathy and polyneuropathy caused by nitrous oxide toxicity: a case report. J Emerg Med 30:1016.e3–1016.e6
Rosenberg H, Orkin FK, Springstead J (1979) Abuse of nitrous oxide. Anesth Analg 58:104–106
Alt R, Morrissey R, Gang M, Hoffman R, Schaumberg H (2011) Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J Emerg Med 41:378–380
Singer M, Lazaridis C, Nations S, Wolfe G (2008) Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review. Muscle Nerve 37:125–9
Waclawik A, Luzzio C, Juhasz-Pocsine K, Hamilton V (2003) Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels. Wis Med J 102:43–45
Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado Z (2006) Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med 21(10):1063–1068
Berlit P, Ringelstein A, Liebig T (2004) Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency. Neurology 63(3):592
Jaiser S, Winston G (2010) Copper deficiency myelopathy. J Neurol 257(6):869–881
Lu C, Yao M, Liu H, Chen Y (2007) MRI findings of intrathecal chemotherapy related myelopathy in two cases: mimicker of subacute combined degeneration. J Neuroimaging 17(2):184–187
Pandey S (2011) Magnetic resonance imaging of the spinal cord in a man with tabes dorsalis. J Spinal Cord Med 34(6):609–611
Sartoretti-Schefer S, Blatter T, Wichmann W (1997) Spinal MRI in vacuolar myelopathy and correlation with histological findings. Neuroradiology 39:865–869
Stacy CB, Di Rocco A, Gould R (1992) Methionine in the treatment of nitrous oxide-induced neuropathy and myeloneuropathy. J Neurol 239:401–403
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rheinboldt, M., Harper, D., Parrish, D. et al. Nitrous oxide induced myeloneuropathy: a case report. Emerg Radiol 21, 85–88 (2014). https://doi.org/10.1007/s10140-013-1152-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10140-013-1152-6